Literature DB >> 3109872

The role of arachidonic acid metabolites in renal homeostasis. Non-steroidal anti-inflammatory drugs renal function and biochemical, histological and clinical effects and drug interactions.

M Dunn.   

Abstract

Prostaglandins (PG) E2 and I2 have a number of effects on renal function, such as causing vasodilatation, increasing the glomerular filtration rate, sodium chloride excretion, water excretion, and stimulating renin secretion. Studies in dogs have shown that reductions in renal blood flow associated with angiotensin II administration are accompanied by increased synthesis of vasodilatory PGE2 followed by a compensatory increase in blood flow. Moreover, in rats and dogs, non-steroidal anti-inflammatory drugs (NSAIDs) markedly augment the reductions in renal blood flow associated with angiotensin II administration. Clinical use of NSAIDs can induce 1 of 2 types of renal syndromes in patients with certain predisposing conditions. These syndromes are ischaemic acute renal failure and papillary necrosis or, rarely, an idiosyncratic reaction. It is believed that the effects of cyclo-oxygenase inhibitors on renal function are most important in patients with these predisposing conditions because in many of these conditions there is increased synthesis of renal PGE2 and PGI2 to compensate for abnormally high plasma concentrations of vasoconstrictor hormones. Angiotensin II produces a concentration-dependent contraction of isolated rat glomeruli or mesangial cells which is potentiated by pretreatment with indomethacin or meclofenamate. Pretreatment with arachidonic acid, or addition of exogenous PGE2, inhibits the angiotensin-mediated glomerular contraction. Stable endoperoxide analogues, which mimic the effects of thromboxane A2, induce a similar glomerular contraction to angiotensin. Similar findings were recorded using isolated rat mesangial cells. Mesangial cell contraction is believed to reduce the filtration surface area of the glomerulus and, therefore, the glomerular filtration rate. In these cells angiotensin II not only induces contraction but also increases the rate of synthesis of PGE2. Associated with the acute reduction in renal function after induction of an immune glomerular nephritis in rats, there is a marked increase in glomerular thromboxane synthesis. The thromboxane synthetase inhibitor dazoxiben inhibits this increase and prevents the acute renal changes which occur in untreated animals during the first 3 hours after antibody injection. However, thromboxane synthetase inhibitors have no influence on renal function when nephrotoxic serum nephritis has been established for 14 days. In conclusion, maintenance of adequate renal function would seem to be dependent on a balance of substances causing mesangial relaxation (PGE2 and PGI2) and contraction (thromboxanes, endoperoxides and leukotrienes).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109872     DOI: 10.2165/00003495-198700331-00009

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  28 in total

1.  Adverse effects of non-steroidal anti-inflammatory drugs on the kidney.

Authors:  M T Stillman
Journal:  Minn Med       Date:  1984-10

Review 2.  Nonsteroidal antiinflammatory drugs and renal function.

Authors:  M J Dunn
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

3.  Contractile effects of TxA2 and endoperoxide analogues on cultured rat glomerular mesangial cells.

Authors:  P Mené; M J Dunn
Journal:  Am J Physiol       Date:  1986-12

4.  The renal haemodynamic and excretory actions of prostacyclin and 6-oxo-PGF1 alpha in anaesthetized dogs.

Authors:  T W Hill; S Moncada
Journal:  Prostaglandins       Date:  1979-01

5.  Aspirin-induced depression of renal function.

Authors:  R P Kimberly; P H Plotz
Journal:  N Engl J Med       Date:  1977-02-24       Impact factor: 91.245

6.  Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.

Authors:  R D Zipser; J C Hoefs; P F Speckart; P K Zia; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

7.  Prostaglandin and thromboxane synthesis by rat glomerular epithelial cells.

Authors:  A S Petrulis; M Aikawa; M J Dunn
Journal:  Kidney Int       Date:  1981-10       Impact factor: 10.612

8.  Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy.

Authors:  M Galler; V W Folkert; D Schlondorff
Journal:  JAMA       Date:  1981-07-10       Impact factor: 56.272

9.  Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin.

Authors:  L A Scharschmidt; M J Dunn
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  The effect of meclofenamate on renal blood flow in the unanesthetized dog: relation to renal prostaglandins and sodium balance.

Authors:  M C Blasingham; R E Shade; L Share; A Nasjletti
Journal:  J Pharmacol Exp Ther       Date:  1980-07       Impact factor: 4.030

View more
  17 in total

Review 1.  Salicylates revisited. Are they still the hallmark of anti-inflammatory therapy?

Authors:  S H Roth
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

2.  Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects.

Authors:  B Cardario; A A McKinnon
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

3.  Ischaemia and mediator release: interrelationship in antigen-challenged sensitized guinea-pig kidney.

Authors:  N A Abdullah; E S Assem
Journal:  Agents Actions       Date:  1990-04

Review 4.  Renal effects of peptic ulcer therapy.

Authors:  E Burgess; D Muruve
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

5.  Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant Recipients.

Authors:  Jordan M Chiasson; Cory E Fominaya; Mulugeta Gebregziabher; David J Taber
Journal:  Transplantation       Date:  2019-12       Impact factor: 4.939

6.  Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives.

Authors:  Souraya Domiati; Ahmed El-Mallah; Asser Ghoneim; Adnan Bekhit; Heba Abd El Razik
Journal:  Inflammopharmacology       Date:  2016-06-24       Impact factor: 4.473

Review 7.  Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.

Authors:  Thomas Hedner; Ola Samulesson; Peter Währborg; Hans Wadenvik; Kjell-Arne Ung; Anders Ekbom
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Prostanoids and blood pressure: which way is up?

Authors:  Helene Francois; Thomas M Coffman
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

9.  The effect of indomethacin on systemic and renal hemodynamics in neonatal piglets during experimental endotoxemia.

Authors:  Nicholas Furtado; Ulf H Beier; Sema Rao Gorla; Linda Fornell; Adisorn Lumpaopong; Jayant Radhakrishnan; Eunice John
Journal:  Pediatr Surg Int       Date:  2008-05-29       Impact factor: 1.827

Review 10.  Prostanoids in paediatric kidney diseases.

Authors:  H W Seyberth; A Leonhardt; B Tönshoff; N Gordjani
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.